Cargando…
Diisothiocyanate-Derived Mercapturic Acids Are a Promising Partner for Combination Therapies in Glioblastoma
[Image: see text] Glioblastoma represents the most aggressive tumor of the central nervous system. Due to invasion of glioblastoma stem cells into the healthy tissue, chemoresistance, and recurrence of the tumor, it is difficult to successfully treat glioblastoma patients, which is demonstrated by t...
Autores principales: | Xu, Pengfei, Westhoff, Mike-Andrew, Hadzalic, Amina, Debatin, Klaus-Michael, Winiarski, Lukasz, Oleksyszyn, Jozef, Wirtz, Christian Rainer, Knippschild, Uwe, Burster, Timo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867792/ https://www.ncbi.nlm.nih.gov/pubmed/35224353 http://dx.doi.org/10.1021/acsomega.1c06169 |
Ejemplares similares
-
Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells
por: Burster, Timo, et al.
Publicado: (2021) -
Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells
por: Burster, Timo, et al.
Publicado: (2021) -
The limitations of targeting MEK signalling in Glioblastoma therapy
por: Selvasaravanan, Karthika D., et al.
Publicado: (2020) -
Application of an Activity-Based Probe to Determine Proteolytic Activity
of Cell Surface Cathepsin G by Mass Cytometry Data Acquisition
por: Gärtner, Fabian, et al.
Publicado: (2020) -
Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
por: Westhoff, Mike-Andrew, et al.
Publicado: (2022)